Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer
![](/xmlui/themes/Mirage2//images/mime.png)
Access
info:eu-repo/semantics/closedAccessDate
2016Author
Salman, TarıkBilici, Ahmet
Arslan, Çağatay
Varol, Umut
Yıldız, İbrahim
Akyol, Murat
Yıldız, Yaşar
Küçükzeybek, Yüksel
Alacacıoğlu, Ahmet
Yılmaz, Uğur
Metadata
Show full item recordCitation
Salman, T., Bilici, A., Arslan, Ç., Varol, U., Yıldız, İ., Akyol, M. ... Yılmaz, U. (2016). Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer. Gastrointestinal Cancers Symposium. San Francisco, California, January 21-23, 2016. https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615Abstract
...
WoS Q Kategorisi
Q1Source
Gastrointestinal Cancers SymposiumVolume
34Issue
4Collections
- Bildiri Koleksiyonu [516]
- WoS İndeksli Yayınlar Koleksiyonu [6677]